Study in Healthy Volunteers to Establish the BioEquivalence of Two Formulations of BG00012
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This is an open-label, single-center, 2 period crossover, PK profile study. Each subject will
be randomized to 1 of 2 treatment sequences. Both treatment sequences will be enrolled
concurrently.